A protein, called TRPC6, could hold the key to treating one of the most common and aggressive brain tumours in adults, according to biomedical researchers at the University of Central Florida.
A protein, called TRPC6, could hold the key to treating one of the most common and aggressive brain tumours in adults, say biomedical researchers at the University of Central Florida.
Glioblastoma multiforme (GBM), the type of malignant brain tumour that killed the late U.S. Sen. Edward Kennedy, is difficult to treat because it spreads cancerous cells to other parts of the brain very quickly.There is no cure, and treatments have limited success.
They consist of surgically removing the tumor from the brain, followed by radiation therapy and chemotherapy. About half of the patients don't survive for more than a year after their diagnosis And thus the role of TRPC6 discovered at UCF is so promising.
"Collectively, our studies indicate that TRPC6 is a key mediator of tumor growth of GBM. It may be a promising therapeutic target in the treatment of human GBM," said Sic L. Chan, the UCF assistant professor of Neuroscience who led the team of scientists.
TRPC6 is a receptor channel protein found in most, if not all, cells in the body. It promotes cell growth during development of the central nervous system.
The researchers ran several experiments with cancerous brain tissue obtained from Florida Hospital in Orlando and Duke University Medical Center.
Advertisement
It is the first time such findings have been made with this particular kind of brain tumour.
Advertisement
Source-ANI
THK